CYP2U1 antibody
Principal name
CYP2U1 antibody
Alternative names for CYP2U1 antibody
Cytochrome P450 2U1
Ncbi ID
9606, NP_898898.1, NM_183075, NP_082092.2, NM_027816, NM_001024779
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P), Immunocytochemistry/Immunofluorescence (ICC/IF)
Background of CYP2U1 antibody
- Kit Component:
- - KN304150G1, Cyp2u1 gRNA vector 1 in pCas-Guide vector
- KN304150G2, Cyp2u1 gRNA vector 2 in pCas-Guide vector
- KN304150D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Western Blot analysis of CYP2U1 expression in transfected 293T cell line (H00113612-T01) by CYP2U1 MaxPab polyclonal antibody.Lane 1: CYP2U1 transfected lysate(18.48 KDa).Lane 2: Non-transfected lysate.
Human Jurkat; WB Suggested Anti-CYP2U1 Antibody. . Titration: 1.0 ug/ml. . Positive Control: Jurkat Whole Cell; CYP2U1 antibody - middle region (ARP61922_P050) in Human Jurkat cells using Western Blot
Immunohistochemical analysis of Cytochrome P450 2U1 staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Immunofluorescent analysis of Cytochrome P450 2U1 staining in LOVO cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
Western blot analysis of Cytochrome P450 2U1 expression in LOVO (A); A2058 (B) whole cell lysates.
Western blot analysis of extracts from HeLa cells and Lovo cells, using Cytochrome P450 2U1 antibody.The lane on the right is treated with the synthesized peptide.
Western blot analysis on HeLa cell lysate using Cytochrome P450 2U1 Antibody
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA316010 | CYP2U1 antibody |
||||||
| Rabbit polyclonal Cytochrome P450 2U1 antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA347741 | CYP2U1 antibody |
||||||
| Rabbit Polyclonal Anti-Cytochrome P450 2U1 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | WB |
0.1 mg /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR217710L2V | Lenti ORF particles, Cyp2u1 (GFP-tagged) - Mouse cytochrome P450, family 2, subfamily u, polypeptide 1 (Cyp2u1), 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€1,230.00
|
|
| OriGene Technologies, Inc. | ||
| MR217710L1V | Lenti ORF particles, Cyp2u1 (Myc-DDK-tagged) - Mouse cytochrome P450, family 2, subfamily u, polypeptide 1 (Cyp2u1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,100.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR209549L2V | Lenti ORF particles, Cyp2u1 (GFP-tagged ORF) - Rat cytochrome P450, family 2, subfamily u, polypeptide 1 (Cyp2u1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,230.00
|
|
| OriGene Technologies, Inc. | ||
| RR209549L1V | Lenti ORF particles, Cyp2u1 (Myc-DDK-tagged ORF) - Rat cytochrome P450, family 2, subfamily u, polypeptide 1 (Cyp2u1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,100.00
|
|
| OriGene Technologies, Inc. | ||